Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kriegsmann

Showing results (321-330 of 366) with videos related to

Pageof 37
Sort By:
Translational Lung Cancer Research|December 15, 2022
Multimodal therapy of epithelioid pleural mesothelioma: improved survival by changing the surgical treatment approachLaura V Klotz, Hans Hoffmann, Rajiv Shah, et al.
Frontiers in Oncology|July 16, 2021
Therapeutic and Prognostic Implications of Immune-Related Adverse Events in Advanced Non-Small-Cell Lung CancerLea Daniello, Mariam Elshiaty, Farastuk Bozorgmehr, et al.
Cancers|April 29, 2020
Oligoprogressive Non-Small-Cell Lung Cancer under Treatment with PD-(L)1 InhibitorsStephan Rheinheimer, Claus-Peter Heussel, Philipp Mayer, et al.
Zeitschrift Fur Rheumatologie|May 5, 2017
[Fifteen years of the histopathological synovitis score : Review and further developments of a diagnostic score]V Krenn, G Perino, W Rüther, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 1, 2020
Effect of Increased Lactate Dehydrogenase A Activity and Aerobic Glycolysis on the Proinflammatory Profile of Autoimmune CD8+ T Cells in Rheumatoid ArthritisM Margarida Souto-Carneiro, Karel D Klika, Mónica T Abreu, et al.
Oncoimmunology|February 1, 2021
A gene expression signature associated with B cells predicts benefit from immune checkpoint blockade in lung adenocarcinomaJan Budczies, Martina Kirchner, Klaus Kluck, et al.
ESMO Open|September 4, 2021
Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancerG Mountzios, E Samantas, K Senghas, et al.
Pathology, Research and Practice|July 9, 2017
15 years of the histopathological synovitis score, further development and review: A diagnostic score for rheumatology and orthopaedicsV Krenn, G Perino, W Rüther, et al.
Therapeutic Advances in Medical Oncology|August 19, 2021
Real-world implementation of sequential targeted therapies for EGFR-mutated lung cancerNikolaus Magios, Farastuk Bozorgmehr, Anna-Lena Volckmar, et al.
American Journal of Respiratory and Critical Care Medicine|June 27, 2026
Spatial proteomics profiling reveals oncogene-specific immune niches and prognostic markers in NSCLCRajender Nandigama, Bassem Ben Cheikh, Jochen Wilhelm, et al.
Pageof 37

Showing results (321-330 of 366) with videos related to

Sort By:
Pageof 37
Translational Lung Cancer Research|December 15, 2022
Multimodal therapy of epithelioid pleural mesothelioma: improved survival by changing the surgical treatment approachLaura V Klotz, Hans Hoffmann, Rajiv Shah, et al.
Frontiers in Oncology|July 16, 2021
Therapeutic and Prognostic Implications of Immune-Related Adverse Events in Advanced Non-Small-Cell Lung CancerLea Daniello, Mariam Elshiaty, Farastuk Bozorgmehr, et al.
Cancers|April 29, 2020
Oligoprogressive Non-Small-Cell Lung Cancer under Treatment with PD-(L)1 InhibitorsStephan Rheinheimer, Claus-Peter Heussel, Philipp Mayer, et al.
Zeitschrift Fur Rheumatologie|May 5, 2017
[Fifteen years of the histopathological synovitis score : Review and further developments of a diagnostic score]V Krenn, G Perino, W Rüther, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 1, 2020
Effect of Increased Lactate Dehydrogenase A Activity and Aerobic Glycolysis on the Proinflammatory Profile of Autoimmune CD8+ T Cells in Rheumatoid ArthritisM Margarida Souto-Carneiro, Karel D Klika, Mónica T Abreu, et al.
Oncoimmunology|February 1, 2021
A gene expression signature associated with B cells predicts benefit from immune checkpoint blockade in lung adenocarcinomaJan Budczies, Martina Kirchner, Klaus Kluck, et al.
ESMO Open|September 4, 2021
Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancerG Mountzios, E Samantas, K Senghas, et al.
Pathology, Research and Practice|July 9, 2017
15 years of the histopathological synovitis score, further development and review: A diagnostic score for rheumatology and orthopaedicsV Krenn, G Perino, W Rüther, et al.
Therapeutic Advances in Medical Oncology|August 19, 2021
Real-world implementation of sequential targeted therapies for EGFR-mutated lung cancerNikolaus Magios, Farastuk Bozorgmehr, Anna-Lena Volckmar, et al.
American Journal of Respiratory and Critical Care Medicine|June 27, 2026
Spatial proteomics profiling reveals oncogene-specific immune niches and prognostic markers in NSCLCRajender Nandigama, Bassem Ben Cheikh, Jochen Wilhelm, et al.
Pageof 37